BIT Computer Co., Ltd (KOSDAQ:032850)
4,325.00
-160.00 (-3.57%)
Jun 2, 2026, 3:30 PM KST
BIT Computer Revenue
BIT Computer had revenue of 9.61B KRW in the quarter ending March 31, 2026, with 11.83% growth. This brings the company's revenue in the last twelve months to 37.00B, up 2.20% year-over-year. In the year 2025, BIT Computer had annual revenue of 35.98B, down -2.95%.
Revenue (ttm)
37.00B
Revenue Growth
+2.20%
P/S Ratio
1.84
Revenue / Employee
284.61M
Employees
130
Market Cap
67.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.98B | -1.09B | -2.95% |
| Dec 31, 2024 | 37.07B | 3.62B | 10.81% |
| Dec 31, 2023 | 33.46B | -1.68B | -4.77% |
| Dec 31, 2022 | 35.13B | -1.30B | -3.56% |
| Dec 31, 2021 | 36.43B | -1.58B | -4.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.81T |
| Celltrion | 4.47T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 203.76B |
| Kukje Pharma | 177.97B |
| PharmGen Science | 171.66B |
| LabGenomics | 84.19B |
| Humasis | 32.87B |